Khani, E., Entezari-Maleki, T. Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists. Mol Psychiatry (2022). https://doi.org/10.1038/s41380-022-01545-3
https://www.nature.com/articles/s41380-022-01545-3

This entry was posted in Uncategorized. Bookmark the permalink.

Comments are closed.